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The emergence of plasmid-mediated colistin resistance (mcr genes) threatens the
effectiveness of polymyxins, which are last-resort drugs to treat infections by multidrug-
and carbapenem-resistant Gram-negative bacteria. Based on the occurrence of colistin
resistance the aims of the study were to determine possible resistance mechanisms and
then characterize the mcr-positive Escherichia coli. The research used material from the
Polish national and EU harmonized antimicrobial resistance (AMR) monitoring programs.
A total of 5,878 commensal E. coli from fecal samples of turkeys, chickens, pigs, and
cattle collected in 2011–2016 were screened by minimum inhibitory concentration (MIC)
determination for the presence of resistance to colistin (R) defined as R > 2 mg/L.
Strains with MIC = 2 mg/L isolated in 2014–2016 were also included. A total of
128 isolates were obtained, and most (66.3%) had colistin MIC of 2 mg/L. PCR
revealed mcr-1 in 80 (62.5%) isolates recovered from 61 turkeys, 11 broilers, 2 laying
hens, 1 pig, and 1 bovine. No other mcr-type genes (including mcr-2 to -5) were
detected. Whole-genome sequencing (WGS) of the mcr-1–positive isolates showed
high diversity in the multi-locus sequence types (MLST) of E. coli, plasmid replicons,
and AMR and virulence genes. Generally mcr-1.1 was detected on the same contig
as the IncX4 (76.3%) and IncHI2 (6.3%) replicons. One isolate harbored mcr-1.1 on
the chromosome. Various extended-spectrum beta-lactamase (blaSHV−12, blaCTX−M−1,
blaCTX−M−15, blaTEM−30, blaTEM−52, and blaTEM−135) and quinolone resistance genes
(qnrS1, qnrB19, and chromosomal gyrA, parC, and parE mutations) were present
in the mcr-1.1–positive E. coli. A total of 49 sequence types (ST) were identified,
ST354, ST359, ST48, and ST617 predominating. One isolate, identified as ST189,
belonged to atypical enteropathogenic E. coli. Our findings show that mcr-1.1 has
spread widely among production animals in Poland, particularly in turkeys and appears
to be transferable mainly by IncX4 and IncHI2 plasmids spread across diverse E. coli
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lineages. Interestingly, most of these mcr-1–positive E. coli would remain undetected
using phenotypic methods with the current epidemiological cut-off value (ECOFF). The
appearance and spread of mcr-1 among various animals, but notably in turkeys, might
be considered a food chain, and public health hazard.
Keywords: WGS, mcr-1, colistin resistance, aEPEC, food animal, IncX4, IncHI2
INTRODUCTION
The worldwide increase in the occurrence of antimicrobial
resistance (AMR) and prevalence of multidrug-resistant (MDR)
Gram-negative Enterobacteriaceae challenge our ability to treat
infections in humans and animals, thus resulting in a renewed
interest in old drugs such as polymyxins. Colistin (polymyxin
E), which has been used in veterinary practice for decades
mainly for treating Gram-negative bacteria infections of the
gastrointestinal tract in pigs, poultry and cattle, is nowadays
considered a last-resort drug to treat human infections by
multidrug-, and carbapenem-resistant Gram-negative bacteria.
Together with third, fourth, and fifth generation cephalosporins,
glycopeptides, quinolones, and macrolides, polymyxins are
among the critically important antimicrobials (CIA) for human
medicine (World Human Organization [WHO], 2017) and
should be mainly used for treating the severest human
infections to preserve their effectiveness. Antimicrobials are
used in hospitals and care facilities as well as in veterinary
clinics and on farms. Extensive use of antimicrobials is
recognized as the most important factor selecting for AMR in
bacteria (Centers for Disease Control and Prevention [CDC],
2013). According to the European Surveillance of Veterinary
Antimicrobial Consumption (ESVAC) report, sales of veterinary
antimicrobial agents in 2016 varied from 0.7 to 2,726.5 tons
in the 30 participating countries (European Medicine Agency
[EMA] and European Surveillance of Veterinary Antimicrobial
Consumption [ESVAC], 2018). Notably, polymyxins were
the fifth most sold group of antimicrobials in 2015–2016
(European Medicine Agency [EMA] and European Surveillance
of Veterinary Antimicrobial Consumption [ESVAC], 2017, 2018).
In Poland, colistin sales increased by 35% from 2011 to
2016, reaching their highest value of 5.94 mg per population
correction unit (PCU) in 2015 and exceeding the recommended
maximum sale target of 5 mg/PCU for this antimicrobial
(European Medicine Agency [EMA] and European Surveillance
of Veterinary Antimicrobial Consumption [ESVAC], 2016, 2017,
2018). Currently, there are 26 veterinary medicinal products
containing colistin (Colistini sulfas or colistinum) registered
in Poland as powders for oral solution, with six registered
only in 20171.
In Enterobacteriaceae, resistance to polymyxines was
theorized to be regulated by the two-component systems
PhoP/PhoQ and PmrA/PmrB involved in LPS modifications
(Olaitan et al., 2014). The emergence and spread of plasmid-
mediated colistin resistance (the mcr-1 gene), first described
in China in 2015 (Liu et al., 2016), and poses a threat to the
1http://bip.urpl.gov.pl/pl/biuletyny-i-wykazy/produkty-lecznicze-weterynaryjne
effectiveness of colistin. The mcr-1 gene has been detected
in several bacterial species (Li et al., 2017; Tian et al.,
2017; Torpdahl et al., 2017) in association with different
plasmid types such as IncI2, IncHI2, IncP, IncFIP, and
IncX4 and also inserted into the bacterial chromosome
(Liu et al., 2016; Zurfluh et al., 2016; Hadjadj et al.,
2017; Sun et al., 2018). New mcr genes and their variants
have also been identified: mcr-2 (Xavier et al., 2016), mcr-
3 (Yin et al., 2017), mcr-4 (Carattoli et al., 2017), mcr-5
(Borowiak et al., 2017), mcr-6 (Abuoun et al., 2017), mcr-7
(Yang et al., 2018), mcr-8 (Wang et al., 2018), and mcr-9
(Carroll et al., 2019).
Little is known about the prevalence of colistin resistance
and the occurrence of mcr genes in livestock in Poland.
In 2015, a single case of mcr-1–positive Escherichia coli
was described from a human patient with a urinary tract
infection (Izdebski et al., 2016). This might be the first
evidence from Poland that mcr-mediated colistin resistance
from animals has spread to humans, which would validate
concerns over foodborne transfer of colistin-resistant bacteria
to humans (Grami et al., 2016). Based on investigation of the
occurrence of colistin resistance among E. coli isolated from
food-producing animals in Poland over a 6-year period, the
aim of the study was to determine the resistance mechanisms
among the colistin-resistant isolates. Whole genome sequence
analysis of the mcr-1–positive E. coli strains was made to
elucidate the pathways of dissemination of mcr-1 in food-
producing animals in Poland and highlight possible animal and
public health threats.
MATERIALS AND METHODS
Bacterial Isolates
A total of 5,878 commensal E. coli isolates were obtained
from individual fecal samples collected from turkeys, chickens,
pigs and cattle in 2011–2016, and tested for antimicrobial
susceptibility by minimum inhibitory concentration (MIC)
determination (Sensititre, TREK Diagnostic; EUMVS2 and
EUVSEC plates). The isolates were screened to confirm
the presence of microbiological resistance (R) to colistin
(R> 2 mg/L). Additionally, available isolates with MIC = 2 mg/L
(wild-type isolates) from 2014 to 2016 were included in
the study because they represented colistin MIC values one
dilution step from those considered as non-wild type (NWT).
Isolates were collected as part of the multiannual national
program (2011–2016) and the EU harmonized AMR monitoring
program carried out in 2014–2016 (Decision 2013/652/EU).
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Those programs are based on isolation of commensal E. coli
from the cecal content of samples collected from random
animals at slaughter. The sampling was carried out by veterinary
officers on a by-slaughterhouse basis proportionally to the
annual capacity of the slaughterhouse and at intervals distributed
over the 6-year period. The antimicrobial susceptibility testing
(AST) for ampicillin, azithromycin, cefotaxime, ceftazidime,
chloramphenicol, ciprofloxacin, gentamicin, colistin, nalidixic
acid, meropenem, sulfamethoxazole, tetracycline, tigecycline,
and trimethoprim was interpreted according to the European
Committee on Antimicrobial Susceptibility Testing (EUCAST)
criteria describing epidemiological cut-off values (ECOFFs) for
antimicrobials. The selected isolates were subjected to PCR
targeting the mcr-1 and mcr-2 genes (Cavaco et al., 2016).
Subsequently, resistant isolates were whole-genome sequenced
(WGS) as detailed below. PCR-negative strains were re-tested
phenotypically to confirm the MIC to colistin and screened
for the presence of mcr-1, -2, -3, -4, and -5 using PCR
(Rebelo et al., 2018).
Whole Genome Sequencing
DNA from bacterial cells of the 80 mcr-1–positive isolates was
extracted from nutrient agar plate cultures using a Genomic
Mini Kit (A&A Biotechnology) following the manufacturer’s
recommendations. Sequencing libraries were prepared with the
Nextera XT DNA Sample Preparation Kit (Illumina) according
to the manufacturer’s protocol. Sequencing of the strains was
performed using Illumina MiSeq 2 bp× 250 bp and 2 bp× 300 bp
reads or Illumina HiSeq 2 bp × 150 bp reads, generating on
average 398 Mb per sample (176–673 Mb), which corresponds to
average coverage of 80× (35–135×) in a 5 Mb genome. The raw
reads were processed using bbmerge v36.62 (Bushnell, 2018) to
merge overlapping reads and Trimmomatic v0.36 (Bolger et al.,
2014) to trim adapters and low quality reads. Merged reads
and trimmed unmerged pairs were used to generate assembly
contigs and scaffolds using SPAdes 3.9.0 (Bankevich et al., 2012).
The mean N50 of assemblies was 178 kb (77–433 kb) and the
average number of contigs longer than 1 kb was 102 (40–364).
Six isolates where the mcr gene was not located on the same
contig as a plasmid replicon were subjected to additional Pacific
Biosciences long-read sequencing, three samples per SMRTcell.
The raw PacBio reads were de-multiplexed to subreads using
lima 1.0.0 (Pacific Biosciences) (Topfer, 2018) yielding on average
225 Mb per sample (72–390 Mb), which translates to average 45×
coverage (14.4–78×) of a 5 Mbps genome. The mean subread
length was 3,555 bp (3,183–3,929 bp) and mean basepair quality
13.1 (12.95–13.22). Subreads were used in a hybrid SPAdes
assembly together with raw short Illumina reads. Assembly
analysis with QUAST 4.5 (Gurevich et al., 2013) reported 8–
13 contigs longer than 10 kb per sample and 2.1 Mb average
N50 (0.91–3.9 Mb). The DNA sequences (reads) from the isolates
were deposited in the European Nucleotide Archive (ENA) under
project number PRJEB23993. Specific sequence numbers are
included in Supplementary Table S1. E. coli strains which codes
start from “U” were gathered within antimicrobial resistance
monitoring according to 2013/652/EC and they are included in
the annual EFSA/ECDC reports.
Bioinformatic Data Analysis
Sequences were analyzed for the presence of AMR genes,
virulence genes and plasmid replicons by using the
Center for Genomic Epidemiology (CGE)2 ResFinder
3.1.0 (with database updated on September 10, 2018)
(Zankari et al., 2012), VirulenceFinder 1.5 (February 18,
2016) (Joensen et al., 2014), PlasmidFinder 1.3 (December
15, 2017) (Carattoli et al., 2014), and pMLST v1.4 (December
15, 2017) (Carattoli et al., 2014) web-based tools for typing
of IncHI2 plasmids. The criteria for these tools were: 90%
threshold for identity with the reference and minimum 60%
coverage of the gene length. Multi-locus sequence typing (MLST)
of strains was performed using MLST 1.8 (Carattoli et al.,
2014). The phylogenetic tree of 80 isolates was constructed by
complete linkage clustering using a sequence similarity distance
matrix. The distance matrix was generated by global pairwise
MUMmer 3.23 (Kurtz et al., 2004) alignments between samples’
scaffolds, automated by CONCOCT 0.4.0 (Alneberg et al.,
2014). A phylogenetic tree of IncX4 plasmids was created in a
similar way, using contigs carrying the IncX4 replicon and the
mcr-1 gene. The mcr-1 carrying contigs were identified using
BLAST (Altschul et al., 1990) and mcr-1 sequence AKF16168.1.
The iTol web-based tool (Letunic and Bork, 2016) was used to
visualize the trees.
RESULTS
Occurrence of Colistin Resistance and
mcr-1
Retrospective analysis of MIC data revealed a total of 128 (2.2%)
out of 5,878 commensal E. coli fulfilling the selection criteria
with colistin MICs ranging from 2 to 16 mg/L (Figure 1).
They originated mostly from turkeys (63%) and chickens (23%).
A slight temporal increase of microbiological resistance to
colistin from very low to low (0.7–1.7%) was observed when
considering all E. coli isolates detected in samples from 2011 to
2016 taken from Polish food-producing animals irrespective of
their origin (Figure 2).
The mcr-1 gene was detected in 80 (62.5%) out of the selected
128 isolates, deriving from 76 fecal samples recovered from
turkeys (n = 61), broilers (n = 11), laying hens (n = 2), pigs
(n = 1), and cattle (n = 1). Most of the mcr-1–positive E. coli
originated from individual samples, but in four samples from
turkeys (n = 3) and broilers (n = 1), two different isolates per
sample were identified (Supplementary Table S1). An increase
in occurrence of the mcr-1–positive E. coli was noted in turkey
and chicken samples, respectively from 1.1 and 0.0% in 2011
to 11.6 and 1.7% in 2016 (Figure 3). The CGE ResFinder
tool confirmed the presence of the mcr-1.1 gene in all PCR-
confirmed isolates. No mcr-2, mcr-3, mcr-4, or mcr-5 was
identified either from PCR or the genome analysis in mcr-1–
positive isolates. Noteworthily, the mcr-1.1 was mostly found
(n = 53; 66.3%) in isolates with colistin MIC = 2 mg/L which
is the EUCAST ECOFF and regarded as that of the wild-type
2https://cge.cbs.dtu.dk/services/
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FIGURE 1 | Colistin MIC distribution and occurrence of the mcr-1 and mcr-2 gene among 128 Escherichia coli selected based on colistin MIC > 2 mg/L
(2011–2013) and ≥2 mg/L (2014–2016). ∗ only isolates with MICcolistin ≥ 2 mg/L were tested for mcr-1 and mcr-2 genes. Different MIC values (>4 and 8, 16, and
>16) are result of changed MIC panel in plates. EUMVS2 plate (2–4 mg/L) was used in 2011–2013, EUVSEC plate (1–16 mg/L) in 2014–2016.
FIGURE 2 | Occurrence of isolates meeting the selection criteria (MIC > 2 mg/L for isolates in 2011–2013 and MIC ≥ 2 mg/L for isolates in 2014–2016) and mcr-1
positive commensal and ESBL/ampC producing E. coli from all tested sources (turkeys, chickens, pigs, and cattle), 2011–2016. The occurrence of colistin resistant
and mcr-1 positive isolates when using exclusively EUCAST ECOFF was included (dashed line).
population. Most of these (n = 41; 77.4%) were sampled from
turkeys. Additionally, a mutation in the chromosomal pmrB
gene (Val161→Gly) was detected in one mcr-1.1–positive isolate
with MIC = 2 mg/L.
As shown on the maps of the farm locations from
which mcr-1–positive E. coli was isolated, the colonized farms
were distributed over the country with no specific regional
trend (Figures 4–6).
An MIC ≥ 2 mg/L for colistin could not be confirmed in
any of the re-tested 48 isolates initially suspected but found
negative for mcr-1 and mcr-2, and none of the mcr-1, -2, -3, -4,
or -5 genes were identified by PCR. They were not investigated
further as we considered them either false positives in the initial
testing, or to have eventually lost the mechanisms over prolonged
storage or handling.
Phylogeny and Epidemiology
The MLST revealed 49 ST among the sequenced isolates. In 64
E. coli from turkeys, 41 STs were identified, as were 10 in 14
chicken isolates. The most common types were ST354 and ST359,
which were observed in five isolates each, ST48 and ST617 which
were identified in four isolates each, and ST10, ST58, ST155, and
ST1011 which were represented by three isolates each. Single
isolates represented 32 ST (Figure 7).
The analysis showed high heterogeneity of mcr-1–positive
E. coli independent of source and year of isolation. Isolates
deriving from animals from 27 farms and slaughtered in
27 slaughterhouses (Supplementary Table S2) were clustered
according to their ST. The majority of isolates belonging to
the most numerous STs (i.e., ST48, ST88, ST359, and ST1011)
derived from different animal species (Figure 7) slaughtered
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FIGURE 3 | Occurrence of mcr-1-positive E. coli in Poland isolated from turkey and chicken fecal samples. ∗ isolates collected in multiannual governmental
programs (according to of the Council of Ministers Decisions), ∗∗ isolates deriving from official monitoring according to Decision 2013/652/EC and thus not
encompassing samples from turkeys and broilers in 2015; n1 and n2 indicate the total number of isolates tested for MIC determination from turkeys and chickens
(both broiler and laying hens), respectively. The occurrence of mcr-1 positive strains when using exclusively EUCAST ECOFF during selection of isolates was also
included (dashed line).
in different slaughterhouses (Supplementary Table S1) and
originating from different farms or flocks (data not shown).
In cases where the same ST was found in animals from the
same slaughterhouse and/or farm, the mcr localization and
plasmid profile were often different, as for example with ST354
observed exclusively in turkeys where two isolates deriving from
the same farm but slaughtered in different places had mcr
localized on IncX4 (U16_0311), and chromosome (U16_0259)
(Supplementary Table S1). In a few cases, the same ST (i.e.,
ST354, ST359, ST919, and ST1564) was present among strains
isolated in different years.
Phenotypic and Genetic Traits of
Microbiological Resistance to Additional
Antimicrobials
The mcr-1–positive strains showed resistance to at least two
and up to seven different classes of antimicrobials and had
different resistance gene contents. Seventy-eight (97.5%) mcr-
1-positive E. coli were classified as MDR isolates. Seventy-
nine (98.8%) were resistant to ampicillin and 22 (27.5%)
to cefotaxime and ceftazidime. Resistance to ciprofloxacin
was confirmed in 70 (87.5%), to tetracycline in 61 (76.3%),
to nalidixic acid in 50 (62.5%), to chloramphenicol in 27
(33.8%), to gentamicin in 16 (20.0%), and to tigecycline
in 12 (15.0%). Four of the isolates had an azithromycin
MIC≥ 16 mg/L, which can be interpreted as resistance according
to the tentative ECOFF for this antimicrobial. The strains
were susceptible to meropenem and presented no resistance
genes to carbapenems.
The whole-genome sequencing data revealed the occurrence
of blaTEM−1 in the majority (n = 73; 92.4%) of the ampicillin-
resistant isolates. The genes encoding extended-spectrum
beta-lactamases (ESBLs) and AmpC-type cephalosporinases
were identified in 18 (22.5%) E. coli belonging to 14 STs:
blaSHV−12 was present in five isolates (ST58, ST69, ST359, and
ST1011), blaCTX−M−1, blaTEM−30, and blaTEM−135 in two each
(respectively, ST617, ST1611, ST154, ST617, ST93, and ST5979),
single isolates carried blaCTX−M−15 (ST767), or blaTEM−52C
(ST117) and blaCMY−2 was present in six strains (ST48, ST58,
ST155, ST398, and ST1011) (Figure 7). Fifteen isolates carried
extended-spectrum cephalosporin (ESC) resistance gene in
combination with blaTEM−1. Two isolates, U15_0035X (ST767)
and U16_0016X (ST617), possessed simultaneously two ESC
resistance genes, respectively, blaCTX−M−15 with blaCMY−2 and
blaCTX−M−1 with blaTEM−30. The swine isolate (U15_0035X)
was the only one carrying the blaCTX−M−15 gene.
Analysis of the genetic background of resistance to quinolones
showed chromosomal mutations in the quinolone resistance-
determining region (QRDR) of topoisomerase genes in 63.8%
(n = 51) isolates, resulting in amino acid substitutions in the
gyrA subunit [Ser83→Leu (n = 48); Asp87→Ans (n = 40),
Asp87→Tyr (n = 2)], parC [Ser80→Ile (n = 37), Ser80→Arg
(n = 4); Ser57→Thr (n = 1); Glu84→Gly (n = 3), Glu84→Lys
(n = 2)], and parE [Leu416→Phe (n = 2), Leu460→Asp
(n = 1)]. The gyrB gene remained unaltered. Several silent
mutations irrelevant for quinolone resistance were also noted.
Different patterns combining up to four simultaneous amino
acid substitutions were noted among tested isolates with a
combination of mutations in gyrA S83L, gyrA D87N, and parC
S80I being the most frequent (n = 30) (Figure 7). Plasmid-
mediated quinolone resistance (PMQR) genes were detected in 23
isolates, namely qnrS1 (n = 12) and qnrB19 (n = 11) (Figure 7).
Four of the PMQR carriers also harbored QRDR chromosomal
mutations. Eight isolates carried both ESBL/AmpC and PMQR
determinants. The aac(6′)Ib-cr gene, conferring resistance to
both quinolones and aminoglycosides, was identified in two
strains, occurring along with qnrS1 (U15_0035X), or the set
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FIGURE 4 | Geographical distribution (commune level) of turkey sampling. Single turkey caeca was collected at slaughter and farm of origin was retrieved for
verification of randomization of samples used for isolation of indicator E. coli in 2014 and 2016.
of mutations in gyrA (S83L and D87N) and parC (S80I and
E84G) (U14_0810). A 21.3% portion of the isolates carrying
quinolone resistance mechanisms were also confirmed as ESBL-
or AmpC-producers.
A variety of gentamicin resistance genes was identified.
The sequences revealed genes coding N-acetyltransferases
catalyzing acetyl CoA-dependent acetylation of an amino
group, like aac(3′)-IIa (n = 8) and aac(3′)-IId (n = 5),
and O-phosphotransferases (APH) catalyzing ATP-dependent
phosphorylation of a hydroxyl group, namely aph(3′)-Ia (n = 14)
(Supplementary Table S1). Overall, there was 93.8% genotype–
phenotype correlation for gentamicin resistance. The presence of
genes coding adenyltransferases [aadA1, aadA2, aadA5, aadA24,
and ant(2”)-Ia] was identified in 50 isolates (Supplementary
Table S1). WGS data showed the occurrence of three genes
responsible for macrolide resistance: mph(B), mph(A), and
msr(E)-mph(E) in single isolates with MICs equal to 8, 16,
and 32 mg/L, respectively. Sixty isolates were resistant to
sulfonamides due to sul1 (n = 32), sul2 (n = 39), or sul3 (n = 18). In
5 isolates all three genes occurred simultaneously, while in 23 a set
of two genes was found with sul1 and sul2 being the most frequent
(n = 19). Of the 49 trimethoprim-resistant E. coli, 45 harbored at
least one of the following genes: dfrA1 (n = 33), dfrA12 (n = 2),
dfrA14 (n = 5), dfrA15 (n = 1), dfrA16 (n = 1), and dfrA17 (n = 5).
At least one of the tetracycline resistance genes tet(A) or tet(B)
was carried by 73 isolates, these genes being found, respectively
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FIGURE 5 | Geographical distribution (commune level) of broiler sampling. Single broiler caeca was collected at slaughter and farm of origin was retrieved for
verification of randomization of samples used for isolation of indicator E. coli in 2014 and 2016.
in 60 and 18 E. coli. In five isolates both genes were detected
and tet(M) was additionally identified in one of them. Overall,
there was 100% genotype–phenotype correlation for tetracycline
resistance. In 31 isolates the presence of catA1 (n = 13), catB3
(n = 2), cmlA1 (n = 18), and floR (n = 10) was confirmed.
In four isolates the resistance genes were present despite a
lack of phenotypic resistance to chloramphenicol. Two of them
possessing the cmlA1 gene had MIC = 16 mg/L, one isolate had
two point mutations in cmlA1 and in the last case a fragment of
the catB3 gene was missing (short contig length).
Plasmids and Location of themcr-1 Gene
Escherichia coli positive for mcr-1 carried a wide variety of
plasmid incompatibility group replicons in different proportions
and ranging from 4 up to 11 replicons per strain (Supplementary
Table S1). The most frequent were: IncFIB (AP001918) (n = 64),
ColRNAI (n = 47), Col (MG828) (n = 43), IncFII (n = 40), IncI1
(n = 30), p0111 (n = 24), IncFIC (FII) (n = 21), Col156 (n = 17),
IncX1 (n = 17), IncHI2A (n = 16), IncQ1 (n = 14), and IncN
(n = 9). Plasmid replicons of all other identified plasmids are
noted in Supplementary Table S1.
Sixty-one isolates out of the 80 mcr-1–positive E. coli (76.3%)
harbored plasmids of the IncX4 group with the replicon located
on the same contig of the mcr-1 gene (hereafter IncX4–mcr-1
contigs). In most cases, the mcr-1 gene was the only resistance
gene found on IncX4–mcr-1 contigs, which ranged in size from
10772 to 39252 bp. The isolates U16_0149 and U16_0323 also
contained the qnrS1 and blaTEM−1 genes and IncX1 replicon
located on the IncX4–mcr-1 contig (contig sizes 76785 bp
and 69841 bp, respectively). IncX4–mcr-1 contigs were of high
sequence similarity and clustered independently of the sample
isolation source and sampling year (Figure 8).
In five of the mcr-1–positive E. coli isolates (6.3%), IncHI2
plasmids were found to be mcr-1 carriers. In 4 out of 5 cases
Frontiers in Microbiology | www.frontiersin.org 7 August 2019 | Volume 10 | Article 1753
fmicb-10-01753 August 7, 2019 Time: 17:30 # 8
Zaja˛c et al. Colistin Resistant E. coli in Poland
FIGURE 6 | Geographical distribution (district level) of mcr-1 positive E. coli isolation sites.
the mcr-carrying plasmid was identified using PacBio data as
it was not possible to link the plasmid replicon with the mcr-1
gene using only short Illumina reads. All the IncHI2–mcr-1
plasmids were subtyped as pST4. On the IncHI2–mcr-1 contig
(234213 bp) of the U16_0565X isolate additional resistance genes
were identified as follows: aadA1, aadA2, blaTEM−1B, catA1,
cmlA1, sul1, and tet(A). This isolate possessed the blaTEM−52C
gene located on the other contig (8917 bp). On the IncHI2–mcr-
1 contig (235356 bp) of U16_0288X, aac(3)-IIa, aadA1, aadA2,
blaTEM−1C, sul1, cmlA1, dfrA1, tet(A), aph(3′′)-Ib, and aph(6)-
Id were also found. The presence of the aph(3′)-Ia gene was
confirmed on the relevant contig (201917 bp) of U16_0579.
No other plasmid replicons except IncHI2 were annotated
on those contigs.
Three isolates (3.7%) possessed both the IncHI2 and IncX4
replicons, but mcr-1 was associated with IncX4. In one strain
(U16_0259) a chromosomal location of the mcr-1 gene was
confirmed (data not shown). In 15.0% (n = 12) of isolates no
plasmid replicons were found on contigs carrying the mcr-1 gene
(ranging in size from 2587 to 57048 bp) but the presence of
the IncX4 or IncHI2 replicon in the assembly was confirmed.
A curiosity is that in two E. coli (ID U16_0115 and U16_0115X)
isolated from the same sample, the mcr-1 genes were located on
different incompatibility group plasmids (IncX4 or IncHI2).
Virulence Genes
The virulence genes were variable among isolates
(Supplementary Table S1). Of the 80 E. coli sequences, six
contained one virulence gene, whereas the remainder carried up
to 10 virulence genes. The most common were: gad (n = 72),
iss (n = 62), iroN (n = 56), lpf A (n = 41), cma (n = 28), mchF
(n = 25), astA (n = 19), air (n = 15), eilA (n = 13), and tsh (n = 10),
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FIGURE 7 | Phylogeny of mcr-1-positive E. coli (sequence types, year and source of isolation, and map of phenotypic resistance and resistance genes). Full and
empty square mean presence and absence of antimicrobial resistance (AMR) gene, respectively, whereas empty space means non-defined or not tested.
(A) Resistance profiles (black): ampicillin, azithromycin, cefuroxime, ceftazidime, chloramphenicol, ciprofloxacin, gentamicin, colistin, nalidixic acid, meropenem,
sulphonamides, tetracycline, tigecycline, and trimethoprim (Sensititre EUSVEC MIC panel). (B) Aminoglycoside resistance genes (green): aac(3)-IIa, aac(3)-IId,
aadA1, aadA2, aadA5, aadA24, aadB, aph(3′)-Ia, aph(3′)-Ic, aph(3′′)-Ib, and aph(6)-Id. (C) Beta-lactam resistance genes (blue): blaTEM−1A, blaTEM−1B, blaTEM−1C,
blaTEM−30, blaTEM−135, blaTEM−52C, blaCMY−2, blaSHV−12, blaOXA−1,blaCARB−2, and blaCTX−M−1. (D) Quinolone resistance genes: plasmid-mediated quinolone
resistance (PMQR, brown): qnrS1, qnrB19; mutations in quinolone resistance determining regions (QRDR, violet): gyrA S83L, gyrA D87N, gyrA D87Y, parC S80I,
parC S80R, parC S57T, parC E84G, parC E84K, parE L416F, and parE L460D. (E) Sulphonamide resistance genes (dark brown): sul1, sul2, and sul3.
(F) Tetracycline resistance genes (light brown): tet(A), tet(B), and tet(M).
whereas cba, celb, ireA, vat, capU, iha, and mcmA were found in
single isolates. We found no correlation of virulence genes with
sample source or sampling year. Isolates were characterized with
different sets of virulence genes. Notably, one isolate (U14_0002)
presented a unique set of virulence genes (cif, eae, espA, espB, espF,
nleB, tccP, and tir) that designated it as atypical enteropathogenic
E. coli (aEPEC) group (Supplementary Table S1).
DISCUSSION
Based on screening of colistin MIC values in E. coli derived
from various monitoring programs on AMR in 2011–2016, we
collected extensive information about the occurrence of the
mcr-1 gene in E. coli isolated from food-producing animals
in Poland. Detailed characterization of mcr-1–positive isolates
from several hosts, different geographical locations, and a
range of sampling years included analysis of the phenotypic
AMR to a broad range of antimicrobials and its genetic
background, the presence of virulence genes, plasmid replicons,
and ST identification.
Many European countries reported the occurrence of
colistin resistance in E. coli deriving from both humans
and animals (Hasman et al., 2015; Irrgang et al., 2016;
Malhotra-Kumar et al., 2016; Perrin-Guyomard et al., 2016;
Carattoli et al., 2017; Duggett et al., 2017; Hartl et al., 2017;
Kawanishi et al., 2017; Apostolakos and Piccirillo, 2018). In
Poland, we observed a slight increase in colistin resistance
in E. coli and also in the prevalence of mcr-positive isolates
originating from healthy livestock from 0.7 to 1.7% and 0.2 to
3.7%, respectively in the analyzed time frame, irrespective of the
animal of origin. The overall occurrence of colistin resistance
in turkeys was higher than in chickens but it still remained low
compared to data from some European countries (European
Food Safety Authority [EFSA], 2018).
Escherichia coli totaling 53 mcr-positive E. coli were identified
after including isolates with MICcolistin = 2 mg/L, which is
the EUCAST epidemiological cut-off delimiting the wild-type
population. Applying this criterion, the prevalence was 3.7%
mcr-1–positive E. coli rather than 0.8% in Poland in 2016.
Detection of the mcr gene in wild-type isolates was reported
(Fernandes et al., 2016; Lentz et al., 2016; Hadjadj et al., 2017;
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FIGURE 8 | Phylogenetic relationship of contigs with mcr-1 and IncX4 plasmid replicon extracted from the genomes of 61 E. coli isolates by source and year of
E. coli isolation. Complete sequence of IncX4 plasmid with accession number KU761327.1 from GenBank was used as the reference.
Wang et al., 2017; Zhou et al., 2017) and might result from a
non-functional mcr-1 gene (Terveer et al., 2017). Some reports
indicate the possibility of deactivation of mcr-1 by insertion
of an IS1294b element and its reactivation by the loss of that
element under colistin selection pressure (Zhou et al., 2018).
In the current study, all of the mcr-1 had the typical sequence
of the mcr-1.1 gene. In some cases, the wild-type concentration
MICcolistin = 2 mg/L could result from a limitation in the MIC
determination method where one dilution step difference is
permissible. It should therefore be considered during selection of
suspected isolates. Except for one isolate, the presence of mcr-1
was not associated with a high level of resistance (MIC> 4 mg/L)
to colistin and the presence of a chromosomal resistance
mechanism in one of the isolates did not lead to elevated colistin
MIC values either (MIC = 2 mg/L). There was a noted presence in
Brazil of the mcr-1 gene in wild type isolates derived from poultry
confirmed as never exposed to polymyxin during their entire lives
(Lentz et al., 2016).
In some cases the lack of genotype–phenotype correlation in
isolates with resistance genes but without phenotypic resistance
to chloramphenicol could result from the limitation of the MIC
method. In others the reason could be substitutions found in the
relevant gene. In an isolate carrying the catB3 gene the lack of
genotype–phenotype correlation could not be identified due to
lack of a fragment gene at one end of the contig.
Despite several mcr-types and their variants being described
in isolates from animals across Europe (Rebelo et al., 2018), our
study suggests only mcr-1.1 being present in Polish livestock,
the first cases dating back to 2011. For yet unknown reasons,
but in concordance with data from Germany and France, the
highest occurrence of mcr-1–positive E. coli was detected in
turkeys (Irrgang et al., 2016; Perrin-Guyomard et al., 2016).
We speculate it could be related to the longer life span of
these animals compared to chickens, and consequently to a
longer length of exposure to selective pressure favoring antibiotic
resistance. Colistin is used for treatment of gastrointestinal
infections in animals, but in some countries low doses
may be used as a growth promoter (Kempf et al., 2013;
Fernandes et al., 2016). However, this practice is not allowed in
Poland or the other EU countries (European Medicine Agency
[EMA] and European Surveillance of Veterinary Antimicrobial
Consumption [ESVAC], 2017). The proliferation of mcr-1–
carrying E. coli, only occasionally found in 2011 but reaching
a case count of several dozen by 2016, raises the question
of the effects of excessive colistin use in animal husbandry.
Worth noting is that in Poland, unlike other animal species,
most of the turkey population is raised from imported one-
day-old poults or hatching eggs and it might be an additional
way for resistant isolates to be introduced to Polish farm
environments. Some research indicates that the introduction of
resistant bacteria may have been through imported breeding
animals (Mo et al., 2014).
Horizontal transfer via plasmids plays an important role in the
dissemination of antibiotic resistance genes. The IncX4 plasmid
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is considered one of the most prevalent carriers of the mcr-
1 gene in Enterobacteriaceae (Johnson et al., 2012; Matamoros
et al., 2017; Sun et al., 2017). Our study showed that mcr-
1 was associated with IncX4 plasmids in the vast majority
(76.3%) of isolates, and with IncHI2 plasmids, another well-
known mcr-1 vector (Matamoros et al., 2017; Sun et al., 2018)
in a few (6.3%) isolates. The fact that in one sample two
different E. coli were found with mcr-1 located on different
plasmids (IncX4 and IncHI2) might evidence a parallel route
of resistance spread but we cannot exclude transfer across the
plasmids. Furthermore, occurrence of the mcr-1 gene on the
chromosome shows that plasmid-mediated colistin resistance
genes might become fixed into specific E. coli populations and
spread vertically.
Most of the tested isolates were genetically unrelated, which
has also been observed in other reports on mcr-1–positive
E. coli (Veldman et al., 2016). One of the reported E. coli
ST 10, identified in 3 isolates, has been previously described
in relation to mcr-1 (Yang et al., 2017), and is considered
a reservoir of this gene (Matamoros et al., 2017). The STs
exhibited genetic diversity and were not related to animal source,
geographic area, or isolation year. The identification of the
same ST (i.e., ST919, ST354, and ST1564) in strains deriving
from the same animal source but isolated in different years,
or even in strains isolated from different species and in some
cases harboring the mcr-1 gene on different plasmids proves
the wide dissemination of plasmid-mediated colistin resistance
over the whole country. The study shows, in the light of the
ESVAC data on colistin sales (European Medicine Agency
[EMA] and European Surveillance of Veterinary Antimicrobial
Consumption [ESVAC], 2017), that the phenomenon is
probably a result of wide colistin selection pressure and
plasmid dissemination, and not due to the spread of specific
bacterial clones (El Garch et al., 2017; Wang et al., 2017). In
Poland, sales of colistin still remain above the maximum sale
target (European Medicine Agency [EMA] and European
Surveillance of Veterinary Antimicrobial Consumption
[ESVAC], 2018). External introduction, transmission of
plasmids, and dissemination under selection pressure create the
potential for the mcr-1 gene to become established in Polish
food-producing animals.
Of significance is that almost all mcr-1.1–positive isolates
were MDR including the compounds considered CIA (World
Human Organization [WHO], 2017). They carried a range of
genes encoding resistance to cephalosporins and quinolones.
Some reports have demonstrated the presence of the mcr-1 gene
together with ESBL genes (Robin et al., 2017; Yamaguchi et al.,
2018). Therefore mcr-1–positive E. coli should be considered a
reservoir not only of the colistin resistance gene, but also of those
of PMQR, and ESBL or sets of other resistance genes carried
along with mcr-1 on some plasmids. This is supported by our
finding of the genes encoding for resistance to beta-lactams,
including cephalosporins, aminoglycosides, or sulphonamides
located on the same contig as mcr-1.1 and IncHI2 replicon.
This is a serious concern for veterinary medicine and also for
human health since direct transmission of resistant isolates from
animals to humans has been confirmed (Marshall and Levy,
2011). The genes found in the current study did not differ
from the ones identified previously in E. coli occurring in the
healthy animal population (Wasyl, 2014; Lalak et al., 2016).
The blaCTX−M−15 gene, which occurs in isolates responsible for
nosocomial infections in Poland (Empel et al., 2008) was found
in this study in only a single pig isolate.
The aEPEC (atypical enteropathogenic Escherichia coli)
isolates are a cause of diarrhea in both humans and animals
(Afset et al., 2004; Almeida et al., 2012). Here, in the collection
of non-clinical E. coli isolates from healthy animals, we identified
mcr-1.1 in a single chicken strain surprisingly carrying several
virulence determinants of the aEPEC phenotype, namely EAST1,
cell cycle inhibiting factor, intimin adherence protein Eae,
secreted proteins EspA, EspB, and EspF type III secretion
system effector NleB, Tir-cytoskeleton coupling protein, and
translocated intimin receptor Tir. The strain carried also
additional AMR genes combining to afford resistance to 4 classes.
Since the mcr-1.1–positive, multidrug resistant aEPEC should
be considered a vector of both resistance determinants and
pathogens, this finding is worrisome for successive treatment of
animals or humans.
CONCLUSION
The results highlight that poultry, especially turkeys, can be an
important reservoir of mcr-1.1–carrying E. coli strains in Poland.
Our findings indicate an increasing occurrence of mcr-1.1 in
E. coli from turkeys and, to a lesser extent, chickens in Poland
from 2011 to 2016, whereas cases in pigs and cattle appear to
be sporadic in the study period. The mcr-1.1 gene occurred
mainly on the IncX4 and IncHI2 plasmids in a wide diversity
of E. coli harboring multiple resistance genes, virulence genes,
and various plasmid replicons. Thus, dissemination of mcr-
positive plasmids is a probable pathway for plasmid-mediated
colistin resistance to spread in food-producing animals. The
impressive genetic diversity of isolates as well as the association
of colistin resistance with particularly relevant phenotypes (e.g.,
third-generation cephalosporin and fluoroquinolone resistance
as well as aEPEC) call for urgent reduction in the use of colistin
to avoid further selection of co-resistance in E. coli in animal
production and possible animal and public health consequences.
Definitely excluding isolates that are currently considered wild-
type might contribute to silent dissemination of the mcr-positive
ones. Great attention should be given to continuous phenotypic
and genotypic surveillance of AMR and data collection in both
human and veterinary settings, thus enabling intervention to
counteract any rapid dissemination of mcr-1.1–positive E. coli.
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